2-羟甲基-6-甲氧基-1,4-苯醌结构式
|
常用名 | 2-羟甲基-6-甲氧基-1,4-苯醌 | 英文名 | 2-HYDROXYMETHYL-6-METHOXY-1,4-BENZOQUINONE |
---|---|---|---|---|
CAS号 | 50827-57-1 | 分子量 | 168.14700 | |
密度 | 1.32g/cm3 | 沸点 | 343.9ºC at 760mmHg | |
分子式 | C8H8O4 | 熔点 | 155-157ºC(lit.) | |
MSDS | 中文版 美版 | 闪点 | 145ºC | |
符号 |
GHS07 |
信号词 | Warning |
中文名 | 2-羟甲基-6-甲氧基-1,4-苯醌 |
---|---|
英文名 | 2-(hydroxymethyl)-6-methoxycyclohexa-2,5-diene-1,4-dione |
中文别名 | 2-羟甲基-6-甲氧基-1,4-苯并醌 |
英文别名 | 更多 |
密度 | 1.32g/cm3 |
---|---|
沸点 | 343.9ºC at 760mmHg |
熔点 | 155-157ºC(lit.) |
分子式 | C8H8O4 |
分子量 | 168.14700 |
闪点 | 145ºC |
精确质量 | 168.04200 |
PSA | 63.60000 |
折射率 | 1.541 |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H315-H319-H335 |
警示性声明 | P261-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xi |
风险声明 (欧洲) | 36/37/38 |
安全声明 (欧洲) | 26-37/39 |
危险品运输编码 | NONH for all modes of transport |
~88% 2-羟甲基-6-甲氧基-1,4-苯醌 50827-57-1 |
文献:Stevens, Robert V.; Vinogradoff, Anna P. Journal of Organic Chemistry, 1985 , vol. 50, # 21 p. 4056 - 4062 |
~63% 2-羟甲基-6-甲氧基-1,4-苯醌 50827-57-1 |
文献:Deya, Pedro M.; Dopico, Mercedes; Raso, Angel Garcia; Morey, Jeronimo; Saa, Jose M. Tetrahedron, 1987 , vol. 43, # 15 p. 3523 - 3532 |
~57% 2-羟甲基-6-甲氧基-1,4-苯醌 50827-57-1 |
文献:Deya, Pedro M.; Dopico, Mercedes; Raso, Angel Garcia; Morey, Jeronimo; Saa, Jose M. Tetrahedron, 1987 , vol. 43, # 15 p. 3523 - 3532 |
2-羟甲基-6-甲氧基-1,4-苯醌上游产品 3 | |
---|---|
2-羟甲基-6-甲氧基-1,4-苯醌下游产品 1 | |
Properties of pyranose dehydrogenase purified from the litter-degrading fungus Agaricus xanthoderma.
FEBS J. 274(3) , 879-94, (2007) We purified an extracellular pyranose dehydrogenase (PDH) from the basidiomycete fungus Agaricus xanthoderma using ammonium sulfate fractionation and ion-exchange and hydrophobic interaction chromatog... |
|
Role of quinones in the ascorbate reduction rates of S-nitrosoglutathione.
Free Radic. Biol. Med. 49(9) , 1387-94, (2010) Quinones are one of the largest classes of antitumor agents approved for clinical use, and several antitumor quinones are in various stages of clinical and preclinical development. Many of these are m... |
2-Hydroxymethyl-6-methoxy-1,4-benzoquinone |
2,5-Cyclohexadiene-1,4-dione,2-(hydroxymethyl)-6-methoxy |
2-methoxy-6-hydroxymethyl-1,4-benzoquinone |